Company Filing History:
1 out of 269 
1 out of 2 Years Active: 2022
Title: Kamal Srivatava: Innovator in Immunological Treatments
Introduction
Kamal Srivatava is a notable inventor based in New York, NY (US). He has made significant contributions to the field of immunology through his innovative research and development of treatment methods.
Latest Patents
Kamal holds a patent for the "Treatment of immunological disease using berberine nanoparticles." This patent outlines methods for treating immunological conditions, such as allergies, by administering berberine nanoparticles. His work in this area demonstrates a commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Throughout his career, Kamal has worked with prestigious institutions, including the Icahn School of Medicine at Mount Sinai and the Sean N. Parker Foundation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kamal has collaborated with notable colleagues, including Xiu-Min Li and Changda Liu. These partnerships have further enhanced his research and development efforts in immunological treatments.
Conclusion
Kamal Srivatava is a dedicated inventor whose work in immunological treatments showcases his innovative spirit and commitment to improving healthcare. His contributions are paving the way for new therapeutic approaches in the field.